
Glyco-Analysis of a Glycoengineered VHH-Radioligand Therapy Designed for Improved Biodistribution

Bush David, Novartis, 2024
Glyco-Analysis of a Glycoengineered VHH-Radioligand Therapy Designed for Improved Biodistribution
Bush David, Novartis, 2024
Glyco-Analysis of a Glycoengineered VHH-Radioligand Therapy Designed for Improved Biodistribution